Seraph® 100 Microbind® utilization in immunocompromised toddler with adenovirus viremia in conjunction with continuous renal replacement therapy and extracorporeal membrane oxygenation

Seraph® 100 Microbind® 在免疫功能低下且患有腺病毒血症的幼儿中的应用,需联合连续性肾脏替代疗法和体外膜肺氧合治疗

阅读:1

Abstract

The Seraph® 100 Microbind® is an extracorporeal, sorbent hemoperfusion device intended to adsorb pathogens when integrated into extracorporeal circuits. We describe the use of Seraph 100 in an 18-month-old immunocompromised toddler with adenovirus viremia in conjunction with continuous renal replacement therapy and extracorporeal membrane oxygenation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。